Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
29
NVX Quote, Financials, Valuation and Earnings
Last price:
$1.03
Seasonality move
:
-20.37%
Day range:
$1.00 - $1.05
52-week range:
$0.81 - $3.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
24.34x
P/B ratio:
1.59x
Volume:
782.9K
Avg. volume:
1.3M
1-year change:
-37.8%
Market cap:
$162.5M
Revenue:
$5.8M
EPS (TTM):
-$0.48
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NVX
NOVONIX Ltd.
|
-- | -- | -- | -- | $3.30 |
|
AUTLF
Austal Ltd.
|
-- | -- | -- | -- | -- |
|
BXBLY
Brambles Ltd.
|
-- | -- | -- | -- | -- |
|
EESH
EESTech, Inc.
|
-- | -- | -- | -- | -- |
|
GVH
Globavend Holdings Ltd.
|
-- | -- | -- | -- | $23.00 |
|
MAQAF
Atlas Arteria Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NVX
NOVONIX Ltd.
|
$1.02 | $3.30 | $162.5M | -- | $0.00 | 0% | 24.34x |
|
AUTLF
Austal Ltd.
|
$4.05 | -- | $1.7B | 27.00x | $0.02 | 0% | 1.30x |
|
BXBLY
Brambles Ltd.
|
$30.63 | -- | $21.1B | 24.62x | $0.42 | 2.63% | 3.19x |
|
EESH
EESTech, Inc.
|
$0.0025 | -- | $779.5K | -- | $0.00 | 0% | 1,281.86x |
|
GVH
Globavend Holdings Ltd.
|
$3.19 | $23.00 | $585.4K | 0.58x | $0.00 | 0% | 1.68x |
|
MAQAF
Atlas Arteria Ltd.
|
$3.24 | -- | $4.7B | 30.75x | $0.13 | 0% | 47.18x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NVX
NOVONIX Ltd.
|
-- | 0.389 | -- | -- |
|
AUTLF
Austal Ltd.
|
20.8% | 0.161 | -- | 0.85x |
|
BXBLY
Brambles Ltd.
|
45.98% | 0.708 | -- | 0.43x |
|
EESH
EESTech, Inc.
|
-- | 61,902.132 | -- | -- |
|
GVH
Globavend Holdings Ltd.
|
-- | 4.569 | -- | 2.32x |
|
MAQAF
Atlas Arteria Ltd.
|
35.28% | -0.201 | -- | 2.71x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NVX
NOVONIX Ltd.
|
-- | -- | -- | -- | -- | -- |
|
AUTLF
Austal Ltd.
|
-- | -- | 2.25% | 2.76% | -- | -- |
|
BXBLY
Brambles Ltd.
|
-- | -- | 14.78% | 26.28% | -- | -- |
|
EESH
EESTech, Inc.
|
-- | -$201.5K | -- | -- | -- | -$93.1K |
|
GVH
Globavend Holdings Ltd.
|
-- | -- | 73.61% | 73.61% | -- | -- |
|
MAQAF
Atlas Arteria Ltd.
|
-- | -- | 4.21% | 5.38% | -- | -- |
NOVONIX Ltd. vs. Competitors
-
Which has Higher Returns NVX or AUTLF?
Austal Ltd. has a net margin of -- compared to NOVONIX Ltd.'s net margin of --. NOVONIX Ltd.'s return on equity of -- beat Austal Ltd.'s return on equity of 2.76%.
Company Gross Margin Earnings Per Share Invested Capital NVXNOVONIX Ltd.-- -- -- AUTLFAustal Ltd.-- -- $853M -
What do Analysts Say About NVX or AUTLF?
NOVONIX Ltd. has a consensus price target of $3.30, signalling upside risk potential of 223.53%. On the other hand Austal Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that NOVONIX Ltd. has higher upside potential than Austal Ltd., analysts believe NOVONIX Ltd. is more attractive than Austal Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NVXNOVONIX Ltd.1 0 0 AUTLFAustal Ltd.0 0 0 -
Is NVX or AUTLF More Risky?
NOVONIX Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Austal Ltd. has a beta of 0.885, suggesting its less volatile than the S&P 500 by 11.531%.
-
Which is a Better Dividend Stock NVX or AUTLF?
NOVONIX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Austal Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.02 per share. NOVONIX Ltd. pays -- of its earnings as a dividend. Austal Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVX or AUTLF?
NOVONIX Ltd. quarterly revenues are --, which are smaller than Austal Ltd. quarterly revenues of --. NOVONIX Ltd.'s net income of -- is lower than Austal Ltd.'s net income of --. Notably, NOVONIX Ltd.'s price-to-earnings ratio is -- while Austal Ltd.'s PE ratio is 27.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NOVONIX Ltd. is 24.34x versus 1.30x for Austal Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVXNOVONIX Ltd.24.34x -- -- -- AUTLFAustal Ltd.1.30x 27.00x -- --
-
Which has Higher Returns NVX or BXBLY?
Brambles Ltd. has a net margin of -- compared to NOVONIX Ltd.'s net margin of --. NOVONIX Ltd.'s return on equity of -- beat Brambles Ltd.'s return on equity of 26.28%.
Company Gross Margin Earnings Per Share Invested Capital NVXNOVONIX Ltd.-- -- -- BXBLYBrambles Ltd.-- -- $5.9B -
What do Analysts Say About NVX or BXBLY?
NOVONIX Ltd. has a consensus price target of $3.30, signalling upside risk potential of 223.53%. On the other hand Brambles Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that NOVONIX Ltd. has higher upside potential than Brambles Ltd., analysts believe NOVONIX Ltd. is more attractive than Brambles Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NVXNOVONIX Ltd.1 0 0 BXBLYBrambles Ltd.0 0 0 -
Is NVX or BXBLY More Risky?
NOVONIX Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brambles Ltd. has a beta of 0.789, suggesting its less volatile than the S&P 500 by 21.113%.
-
Which is a Better Dividend Stock NVX or BXBLY?
NOVONIX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brambles Ltd. offers a yield of 2.63% to investors and pays a quarterly dividend of $0.42 per share. NOVONIX Ltd. pays -- of its earnings as a dividend. Brambles Ltd. pays out 61.42% of its earnings as a dividend. Brambles Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NVX or BXBLY?
NOVONIX Ltd. quarterly revenues are --, which are smaller than Brambles Ltd. quarterly revenues of --. NOVONIX Ltd.'s net income of -- is lower than Brambles Ltd.'s net income of --. Notably, NOVONIX Ltd.'s price-to-earnings ratio is -- while Brambles Ltd.'s PE ratio is 24.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NOVONIX Ltd. is 24.34x versus 3.19x for Brambles Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVXNOVONIX Ltd.24.34x -- -- -- BXBLYBrambles Ltd.3.19x 24.62x -- --
-
Which has Higher Returns NVX or EESH?
EESTech, Inc. has a net margin of -- compared to NOVONIX Ltd.'s net margin of --. NOVONIX Ltd.'s return on equity of -- beat EESTech, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital NVXNOVONIX Ltd.-- -- -- EESHEESTech, Inc.-- -$0.00 -- -
What do Analysts Say About NVX or EESH?
NOVONIX Ltd. has a consensus price target of $3.30, signalling upside risk potential of 223.53%. On the other hand EESTech, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that NOVONIX Ltd. has higher upside potential than EESTech, Inc., analysts believe NOVONIX Ltd. is more attractive than EESTech, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NVXNOVONIX Ltd.1 0 0 EESHEESTech, Inc.0 0 0 -
Is NVX or EESH More Risky?
NOVONIX Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison EESTech, Inc. has a beta of 6,663.206, suggesting its more volatile than the S&P 500 by 666220.586%.
-
Which is a Better Dividend Stock NVX or EESH?
NOVONIX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EESTech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NOVONIX Ltd. pays -- of its earnings as a dividend. EESTech, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVX or EESH?
NOVONIX Ltd. quarterly revenues are --, which are smaller than EESTech, Inc. quarterly revenues of --. NOVONIX Ltd.'s net income of -- is lower than EESTech, Inc.'s net income of -$201.5K. Notably, NOVONIX Ltd.'s price-to-earnings ratio is -- while EESTech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NOVONIX Ltd. is 24.34x versus 1,281.86x for EESTech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVXNOVONIX Ltd.24.34x -- -- -- EESHEESTech, Inc.1,281.86x -- -- -$201.5K
-
Which has Higher Returns NVX or GVH?
Globavend Holdings Ltd. has a net margin of -- compared to NOVONIX Ltd.'s net margin of --. NOVONIX Ltd.'s return on equity of -- beat Globavend Holdings Ltd.'s return on equity of 73.61%.
Company Gross Margin Earnings Per Share Invested Capital NVXNOVONIX Ltd.-- -- -- GVHGlobavend Holdings Ltd.-- -- $4.4M -
What do Analysts Say About NVX or GVH?
NOVONIX Ltd. has a consensus price target of $3.30, signalling upside risk potential of 223.53%. On the other hand Globavend Holdings Ltd. has an analysts' consensus of $23.00 which suggests that it could grow by 621.3%. Given that Globavend Holdings Ltd. has higher upside potential than NOVONIX Ltd., analysts believe Globavend Holdings Ltd. is more attractive than NOVONIX Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NVXNOVONIX Ltd.1 0 0 GVHGlobavend Holdings Ltd.1 0 0 -
Is NVX or GVH More Risky?
NOVONIX Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Globavend Holdings Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NVX or GVH?
NOVONIX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globavend Holdings Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NOVONIX Ltd. pays -- of its earnings as a dividend. Globavend Holdings Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NVX or GVH?
NOVONIX Ltd. quarterly revenues are --, which are smaller than Globavend Holdings Ltd. quarterly revenues of --. NOVONIX Ltd.'s net income of -- is lower than Globavend Holdings Ltd.'s net income of --. Notably, NOVONIX Ltd.'s price-to-earnings ratio is -- while Globavend Holdings Ltd.'s PE ratio is 0.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NOVONIX Ltd. is 24.34x versus 1.68x for Globavend Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVXNOVONIX Ltd.24.34x -- -- -- GVHGlobavend Holdings Ltd.1.68x 0.58x -- --
-
Which has Higher Returns NVX or MAQAF?
Atlas Arteria Ltd. has a net margin of -- compared to NOVONIX Ltd.'s net margin of --. NOVONIX Ltd.'s return on equity of -- beat Atlas Arteria Ltd.'s return on equity of 5.38%.
Company Gross Margin Earnings Per Share Invested Capital NVXNOVONIX Ltd.-- -- -- MAQAFAtlas Arteria Ltd.-- -- $5.1B -
What do Analysts Say About NVX or MAQAF?
NOVONIX Ltd. has a consensus price target of $3.30, signalling upside risk potential of 223.53%. On the other hand Atlas Arteria Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that NOVONIX Ltd. has higher upside potential than Atlas Arteria Ltd., analysts believe NOVONIX Ltd. is more attractive than Atlas Arteria Ltd..
Company Buy Ratings Hold Ratings Sell Ratings NVXNOVONIX Ltd.1 0 0 MAQAFAtlas Arteria Ltd.0 0 0 -
Is NVX or MAQAF More Risky?
NOVONIX Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Atlas Arteria Ltd. has a beta of 0.539, suggesting its less volatile than the S&P 500 by 46.123%.
-
Which is a Better Dividend Stock NVX or MAQAF?
NOVONIX Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Atlas Arteria Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.13 per share. NOVONIX Ltd. pays -- of its earnings as a dividend. Atlas Arteria Ltd. pays out 210.75% of its earnings as a dividend.
-
Which has Better Financial Ratios NVX or MAQAF?
NOVONIX Ltd. quarterly revenues are --, which are smaller than Atlas Arteria Ltd. quarterly revenues of --. NOVONIX Ltd.'s net income of -- is lower than Atlas Arteria Ltd.'s net income of --. Notably, NOVONIX Ltd.'s price-to-earnings ratio is -- while Atlas Arteria Ltd.'s PE ratio is 30.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NOVONIX Ltd. is 24.34x versus 47.18x for Atlas Arteria Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NVXNOVONIX Ltd.24.34x -- -- -- MAQAFAtlas Arteria Ltd.47.18x 30.75x -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
